tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AXGN Stock Latest News

AxoGen Approves New CFO Compensation and Agreement
Company AnnouncementsAxoGen Approves New CFO Compensation and Agreement
15d ago
8K
AXGN
AxoGen price target raised to $39 from $26 at H.C. Wainwright
PremiumThe Fly
AxoGen price target raised to $39 from $26 at H.C. Wainwright
15d ago
AXGN
AxoGen price target raised to $37 from $27 at Canaccord
PremiumThe Fly
AxoGen price target raised to $37 from $27 at Canaccord
15d ago
AXGN
Midday Fly By: Meta to slash metaverse spending, Salesforce posts Q3 beat
PremiumThe Fly
Midday Fly By: Meta to slash metaverse spending, Salesforce posts Q3 beat
16d ago
BP
DG
AxoGen price target raised to $40 from $30 at Lake Street
PremiumThe Fly
AxoGen price target raised to $40 from $30 at Lake Street
16d ago
AXGN
AxoGen price target raised to $36 from $29 at Jefferies
PremiumThe FlyAxoGen price target raised to $36 from $29 at Jefferies
16d ago
AXGN
AxoGen announces FDA approval of Avance biologics license application
Premium
The Fly
AxoGen announces FDA approval of Avance biologics license application
16d ago
AXGN
AxoGen Secures FDA Approval for Avance Nerve Scaffold
Premium
Company Announcements
AxoGen Secures FDA Approval for Avance Nerve Scaffold
16d ago
8K
AXGN
AxoGen initiated with an Outperform at Mizuho
PremiumThe Fly
AxoGen initiated with an Outperform at Mizuho
19d ago
AXGN
AxoGen price target raised to $26 from $25 at H.C. Wainwright
PremiumThe Fly
AxoGen price target raised to $26 from $25 at H.C. Wainwright
2M ago
AXGN
AxoGen’s Strong Financial Performance and Strategic Advancements Justify Buy Rating
PremiumRatings
AxoGen’s Strong Financial Performance and Strategic Advancements Justify Buy Rating
2M ago
AXGN
AxoGen’s Strong Market Position and Growth Potential Justify Buy Rating
PremiumRatings
AxoGen’s Strong Market Position and Growth Potential Justify Buy Rating
2M ago
AXGN
AxoGen price target raised to $27 from $24 at Canaccord
PremiumThe FlyAxoGen price target raised to $27 from $24 at Canaccord
2M ago
AXGN
AxoGen price target raised to $34 from $26 at Citizens JMP
Premium
The Fly
AxoGen price target raised to $34 from $26 at Citizens JMP
2M ago
AXGN
Axogen Reports Strong Q3 2025 Results, Raises Guidance
Premium
Company Announcements
Axogen Reports Strong Q3 2025 Results, Raises Guidance
2M ago
AXGN
AxoGen’s Earnings Call Highlights Robust Growth and Strategic Progress
PremiumCompany Announcements
AxoGen’s Earnings Call Highlights Robust Growth and Strategic Progress
2M ago
AXGN
AxoGen price target raised to $29 from $25 at Jefferies
PremiumThe Fly
AxoGen price target raised to $29 from $25 at Jefferies
2M ago
AXGN
Axogen Reports Q3 2025 Revenue Growth of 23.5%
PremiumCompany Announcements
Axogen Reports Q3 2025 Revenue Growth of 23.5%
2M ago
8K
AXGN
AxoGen reports Q3 adjusted EPS 12c, consensus 7c
PremiumThe Fly
AxoGen reports Q3 adjusted EPS 12c, consensus 7c
2M ago
AXGN
AxoGen sees FY25 revenue $222.8M, consensus $219.63M
PremiumThe FlyAxoGen sees FY25 revenue $222.8M, consensus $219.63M
2M ago
AXGN
AxoGen’s Avance Nerve Graft Study: A Potential Game-Changer in Nerve Repair
Premium
Company Announcements
AxoGen’s Avance Nerve Graft Study: A Potential Game-Changer in Nerve Repair
2M ago
AXGN
AXGN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AXGN Earnings this Week: How Will it Perform?
2M ago
AXGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >